JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (8): 790-792.doi: 10.3969/j.issn.1005-6483.2022.08.025

Previous Articles     Next Articles

Advances of ubiquitin-proteasome system in the development of esophageal squamous cell carcinoma

  

  1. Department of Thoracic Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
  • Received:2022-07-14 Accepted:2022-07-14 Online:2022-08-20 Published:2022-08-20

Abstract: The proteasome is a multi-protein complex capable of regulating the stability of hundreds of cellular proteins involved in almost all cellular processes.In most cases,proteins must be linked to a chain of ubiquitin molecules in order to be recognized and processed by the proteasome.The ubiquitin-proteasome system(UPS) regulates cell proliferation,apoptosis,angiogenesis and motility,processes that are particularly important in carcinogenesis.There is growing evidence that alterations in the UPS are associated with malignancy.Esophageal squamous cell carcinoma has a high incidence and a poor treatment prognosis in China and Southeast Asia.Therefore,we summarize the current literature on the involvement of UPS in esophageal squamous cell carcinoma to highlight its role in tumor development and to provide information for the study of therapeutic targets.

Key words: esophageal squamous cell carcinoma, ubiquitin-proteasome system

Viewed
Full text
26
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 26

  From local
  Times 26
  Rate 100%

Abstract
264
Just accepted Online first Issue
0 0 264
  From Others
  Times 264
  Rate 100%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!